Effects of Atorvastatin Therapy on the Low-Density Lipoprotein Subfraction, Remnant-Like Particles Cholesterol, and Oxidized Low-Density Lipoprotein Within 2 Weeks in Hypercholesterolemic Patients-Reference-Cited by-同舟云学术

Effects of Atorvastatin Therapy on the Low-Density Lipoprotein Subfraction, Remnant-Like Particles Cholesterol, and Oxidized Low-Density Lipoprotein Within 2 Weeks in Hypercholesterolemic Patients

Published:2003 Issue:10 Volume:67 Page:866-870
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Sakabe Koichi¹,Fukuda Nobuo¹,Wakayama Katsunori¹,Nada Teru¹,Shinohara Hisanori¹,Tamura Yoshiyuki¹

Affiliation:

1. Department of Cardiology and Clinical Research, National Zentsuji Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/67/10/67_10_866/_pdf

Reference42 articles.

1. 1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.

2. 2. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-1009.

3. 3. WOS-COPS Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study. Circulation 1998; 97: 1440-1445.

4. 4. Sasaki S, Nakagawa M, Nakata T, Azuma A, Sawada S, Takeda K, et al. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto. Circ J 2002; 66: 47-52.

5. 5. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: 1087-1095.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk;International Journal of Molecular Sciences;2022-11-04

2. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease;Endocrine Practice;2017-04

3. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis;Endocrine Practice;2012-03

4. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia;European Journal of Pharmacology;2008-08

5. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function;Nutrition, Metabolism and Cardiovascular Diseases;2008-03